Columnist Desiree Lama explores how living with MS led her to confront the comparison trap, ultimately finding strength in ...

Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

Talking to children about a parent’s multiple sclerosis diagnosis can help ease fears and keep your kids feeling connected.

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking and hand function.

People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...